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Abstract
TONSIL CELL PRODUCTS WHICH MODIFY IN VITRO 
PROLIFERATION OF BLOOD LYMPHOCYTES 
by
Thomas Weston Hodge
Human palatine tonsil lymphocytes, when compared to peripheral 
blood lymphocytes (PBL), were In an activated state even though there 
was no in vitro stimulation• When these tonsil lymphocytes were 
cultured In the absence of serum and polyclonal mitogens or antigens, 
the supernatant fluid often inhibited the proliferative response of 
target PBL to con A. The extent of this suppression ranged from 22% 
to 84%, and target cell viability was 90% or greater. There was no 
evidence for the presence of immunoglobulins or a2-macroglobulln in 
whole supernatant fluids. The suppressor was partially denatured at 
80° C and was rendered completely inactive upon exposure to 100° C 
for 5 rain. It was trypsin sensitive, and had an apparent molecular 
weight of 100,000 or greater. The protein adhered strongly to DE-52 
cellulose, and the most active material eluted with 0.4-0.6 M NaCl. 
The suppressor was active In the pH range 5.0 ± 0.6 as demonstrated 
by Isoelectric focusing.
Occasionally, supernatant fluids comprised material which 
augmented the expected response of con A stimulated PBL. The 
augmentor was 30,000 in molecular weight and was eluted from DE-52 
cellulose in the 0.15-0.25 M NaCl range.
Nearly all supernatant preparations tested contained a mltogenlc 
substance which stimulated naive allogeneic human PBL without the 
necessity of co-stlmulatlon by a mitogen. The mltogenlc factor (MF) 
behaved In a dose dependent fashion and was evidently different from 
the augmentor since the MF stimulated PBL independently of lectin co- 
stimulation.
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CHAPTER 1 
INTRODUCTION
In recent times there has been exponential growth in the under­
standing of the mechanisms of the Immune response. One aspect of 
Immunity which has gained particular attention is the area of 
lymphoklne (1) research.
Lymphokines are soluble mediators which can be generated with 
antigens or mitogens, either in vivo or in vitro. They are produced by 
normal thymus-derived T lymphocytes or bursal-equivalent lymphocytes 
and by transformed T cell lines. They function by suppressing or 
helping immune responses, and they may or may not possess antigenic 
determinants encoded by the major histocompatibility complex.
Lymphokines affect a wide variety of cell types in vitro including 
lymphocytes, macrophages, neutrophils, basophils, eosinophils, 
polymorphonuclear leukocytes, thymocytes, bone marrow cells, fibro­
blasts, lymphoid cell lines, osteoclasts, and endothelial cells. In 
vivo, the role of lymphokines remains unclear, but they are assumed 
to be involved in delayed type hypersensitivity, particularly in the 
reticuloendothelial system, in the circulation, and at mucosal sites.
Presently there are 90 such lymphokines which have been identified 
according to function and shown to have distinct molecular character­
istics apart from immunoglobulins. All lymphokines appear to be pro­
teins or glycoproteins of a molecular weight greater than 10,000.
They behave similarly to glycoprotein hormones in that they both affect 
distal targets and are recognized by specific membrane receptors.
Lymphokines may function as monomeric subunits, polymerize to 
larger molecular weight forms, or non-specifically aggregate in the
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presence or absence of serum components (115). They may also be trans­
ported by larger molecular weight proteins such as a2-macroglobulin (32).
Prior to the advent of monoclonal antibodies, it was difficult 
to develop strictly specific antibodies to lymphokines due to the lack 
of substantial amounts of purified material. However, hybridoma 
technology has been Instrumental in producing antibodies specific for 
certain lymphokines because this technique requires only partially 
purified material. It is reasonable then to assume that further ex­
ploitation of hybridoma monoclonal antibodies will facilitate purifi­
cation and biochemical characterization of the various lymphokines.
A comprehensive review of all the lymphokines is a somewhat 
daunting task and is beyond the scope of this dissertation. Instead, 
the reader is referred to other sources for further discussion of this 
expansive topic (2-6). This literature review will focus primarily on 
selected factors which are found in the human and pertinent to the 
work described herein.
The existence of mltogenlc factor in humans was first noted by 
Kaskura and Lowenstein (7) in the supernatant fluids of mixed leuko­
cyte cultures. Using peripheral blood from allogeneic donors, cells 
were mixed and Incubated. The supernatant fluids were added tonon-sensi- 
tized cells which then were examined for blastogenesiB by their 
ability to Incorporate radiolabelled thymidine. Since then, mitogenic 
factors have been redefined operationally as activities that appear 
in supernatant fluids of leukocyte cultures and cause lymphocytes to 
divide and/or synerglstlcally augment cell division Induced by other 
lymphocyte stimulants.
Mltogenlc factors potentially may be produced by one or more
cell types In leukocyte cultures, e.g. lymphocytes, monocytes, and 
neutrophils. The present discussion will concern human lymphocyte 
mltogenlc factor (HLMF) and T cell growth factor (TCGF), which are 
T cell products, and lymphocyte activating factor (LAF) which Is a 
product of macrophages.
A number of Investigators, using a variety of antigens and 
mitogens as stimulatory agents, have successfully Implicated a sub- 
population of thymus-derived cells which, during activated conditions, 
produce human lymphocyte mltogenlc factor (8, 9, 10). Peripheral 
lymphocytes from Mantoux positive individuals, were separated into 
T and B cell populations according to their banding patterns on 
sucrose density gradients (11). By adding purified protein derivative 
of Tuberculin (PPD) (the antigen In this case) to cultures of each of 
these cell typeB, it was shown that only the culture supernatant 
fluids from the T cell population (devoid of PPD) elllcited any 
blastogenlc effect on non-sensltlzed target cells In a subsequent 
assay.
By far the most common antigen system used to stimulate secretion 
of HIMF in vitro Is the mixed lymphocyte culture (MLC) (7, 12, 13, 14). 
This technique involves mixing allogeneic lymphocytes from two donors 
which then stimulate cells In each population to produce a variety of 
lymphokines (13). Treating one of the cell populations with mitomycin 
C prior to mixing, however, Inhibits Its DNA synthesis and permits only 
the untreated population to respond to the treated cells' surface 
antigens (12, 13, 14). This technique is known as the one way MLC and 
is helpful in reducing the number of lymphokine contaminants in the 
supernatant.
In pioneering studies, Chess et al. (9, 15, 16, 17) separated 
lymphocyte populations by immunoaffinity column chromatography and 
discovered that only T cells proliferated In response to cell surface 
antigens In an MLC and consequently produced HLMF (9).
Other evidence Indicating T cell production of HLMF lies in the 
fact that patients with X-linked agammaglobulinemia show normal levels 
of HLMF (8). Since the disease is characterized by a deficiency in 
plasmacytes, it may be assumed the B cell plays a minor role in HLMF 
production. In addition, athymic mice exhibit little or no LMF 
activity while normal mice produce detectable quantities of the 
lymphokine (18).
Findings by Mackler and Altman (18) showed lymphocytes that sponta­
neously rosetted with sheep red cells were capable of Inducing, via a 
soluble mediator, a mltogenlc effect on autologous cells.
Bacterial extracts (19), and products (14) have also been used 
to induced HLMF synthesis. Other antigens which have been used for 
HLMF in vivo production studies Include PPD (15, 20, 21, 22), dinitro- 
chlorobenzene (DHCB) (8, 10, 23) and lymphocytes from donors sensitized 
to tetanus toxoid (8, 17, 23).
Earlier experiments designed to prove the existence of HLMF 
explored the use of individuals sensitive to PPD. Valentine and 
Lawrence (20) observed that (a) when leukocytes from a donor sensitive 
to both PPD and Diptheria-Pertussus-Typhoid (DPT) were Incubated with 
PPD, the resultant supernatant material could transfer delayed hyper­
sensitivity only for TB and not DPT, and (b) incubating cells with PPD 
and then adding the activated supernatant fluid to naive lymphocytes 
caused a 4-25 fold increase in radiolabelled thymidine uptake.
A prerequisite for HLMF production In an antigen system Is that 
the producing cells must be obtained from positive individuals i.e. 
persons previously sensitized to the particular antigen used (13).
A large portion of the Information on HLMF comes from studies of 
mitogen-stimulated lymphocytes; pokeweed mitogen (PVM) (15), phyto- 
hemagglutlnin (PHA) (15, 18), and concanavalin A (con A) (15, 18, 24, 
25, 26) have all been used with moderate success to generate HUtF.
The relative ease with which con A can be removed from culture 
fluids by absorption to cross-linked dextran (Sephadex G-50) makes 
the mitogen useful for stimulating lymphoklne synthesis. The lectin, 
con A, is a metallo-protein (29) containing manganese and calcium ions. 
With a basic subunit of 23,000, con A forms dimers predominant at 
pH 5-6 and tetramers at alkaline pH In solutions of 1 M HaCl (30).
The binding site of con A to lymphocyte cell membranes Is specific for 
a-D-manopyranose, o-D-glucopyranose or sterically similar residues 
(31) and consequently is specifically inhibited by these sugars.
Reports concerning the partial purification of HLMF are difficult 
to compare because of the divergent conditions utilized for the 
production of this lymphoklne. These differences raise the possibility 
that the various investigators are not examining the same factor and 
may account for some of the discrepancies in the biochemical para­
meters of this factor.
Valantlne et al. (20) and Mainl (21) reported that HIHF 
was heat stable at 56° C for 30 minutes , was not removed by 
centrifugation at 100,000 x g and could stimulate both autologous 
and allogeneic lymphocytes. Kashura (7) noted that there was no 
HLMF activity released from dead cells.
6Using actinomycin D, an Inhibitor of protein synthesis, It was 
shown (14) that HLMF was not produced in treated cells stimulated with 
mitogens. This Indicated mltogenlc factor was evidently endogenous. 
Treatment with trypsin or chymotrypsln resulted In loss of lymphoklne 
activity while neuraminidase had no effect (8).
The molecular weight of HLMF is generally accepted to be around 
25,000 (9, 25) as judged by Sephadex chromatography. Other Inves­
tigators (8), however, have noted that HLMF activity was excluded by 
Sephadex C-200 indicating a molecular weight in excess of 100,000,
This may be due to polymeric forms of HLMF or complexes of HLMF with 
a large carrier protein auch as a2-macroglobulln (32).
The Isoelectric point of HLMF is the only other molecular para­
meter measured thus far (19). Seravaili reported that the pi of 
Group A Streptococcal filtrate-stimulated HLMF was 8.0-8.5 sb evi­
denced by the fraction's high mltogenlc activity on target cells.
Recently, Northroff et al. (33) reported that Incubating mono­
nuclear cells i.e. T and B lymphocytes and monocytes, 2 to 5 days before 
the addition of con A dramatically Increased the production of HIMF.
The active material was eluted from a Sephadex G-150 column in two 
peaks at 12,000 to 27,000 and 50,000 to 70,000. The effect of pre- 
lncubatlon was abolished by the addition of fresh mononuclear cells 
leading to the conclusion that suppressor T cells may regulate pro­
duction of HLMF when stimulated with con A.
In addition to studies focusing on HLMF, mouse (28, 34, 38), 
chicken (39), and guinea pig (38, 40-49) mltogenlc factors have been 
similarly investigated.
In the guinea pig, ovalbumin-induced MF had an apparent molecular
7weight of 20,000, a I>20W x cm^/sec, and Sjq^ of
2.4 ± 0.25, and a partial specific volume of 0.71. Zt wsb heat stable 
at 60° C for 20 minutes or at 56° C for one hour (47).
Geczy (43) reported that MLC-lnduced and soluble-antigen-induced 
MF were separate molecular entitles In the guinea pig. The antigen- 
stimulated MF, poBsesslng a molecular weight of 20,000-25,000 and an 
Isoelectric point of 7.0-7.5, was unaffected by L-fucose whereas, the 
MLC-lnduced MF, weighing 15,000-18,000 with a pi of 6.0-6.5, was 
Inhibited by L-fucose.
Antibodies prepared against MLC-MF Inhibited the MLC reaction.
This antibody did not affect the response of lymphocytes to FHA or PPD 
and had no suppressive effect on PPD-MF. Antibodies could not be 
absorbed out with lymphocytes; thus, the antibodies probably were 
directed against the MF rather than membrane antigens (43).
Soon after the observation that lymphocytes were capable of self 
renewal came the realization that purified T cells could be maintained 
in continuous exponential proliferative culture provided that condi­
tioned medium from PHA-stlmulated lymphocytes was present (50, 51).
This discovery was confirmed and expanded by Glllis et al
(52) who concluded that a soluble T cell product was the active 
moiety responsible for this effect and suggested the name T cell 
growth factor (TCGF). More recent studies showed that the mltogenlc 
stimulus was delivered to the cell by TCGF rather than the lectin or 
antigen. Furthermore, it was found that the presence of a macrophage- 
derived factor was required for the biological expression of TCGF
(53) .
This adherent cell product was termed lymphocyte activating 
factor (LAF). LAF alone is not mltogenlc for T lymphocytes nor does 
it support continuous T cell proliferation. Instead, macrophages, 
when activated by antigens or mitogens, secrete LAF which in turn 
stimulates T cells to produce TCGF and augments the effect of the 
mitogen (54).
The biological assay for LAF relies heavily on using high densi­
ties of purified mouse thymocytes as target cells. In the presence 
of a suboptlmal concentration of a T cell mitogen, i.e. PHA or con A, 
and LAF, the thymocyteB exhibit a marked proliferative response that 
Is dependent on LAF concentration (54).
Since LAF Is a macrophage-derived product, mitogens specific for 
these cell types, particularly 11 popolysaccharide (LPS), enhance its pro­
duction (55) . Other Inducers include phagocytic stimuli such as phorbol 
myrlstate acetate, antigen-antlbody complexes, and latex particles. LAF 
is also produced in mixed lymphocyte cultures which contain monocytes.
Although LAF may appear In an aggregated form, the apparent 
molecular weight of the monomer was determined to be 13,000-15,000 
by gel filtration (56-59). That the molecule was protein was shown 
by its sensitivity to chyraotrypsin.
LAF was apparently heterogeneous with respect to charge since 
more than one charged species was resolved by DEAE-lon-exchange 
chromatography and isoelectric focusing (58, 61). Lachman et al.
(58) reported three isoelectric points at pH 5.2, 5.9, and 7.0, 
with the major component of activity at pH 7.0. The observed hetero­
geneity probably was not the result of variation In sugar moieties 
since LAF was unaffected by treatment with sodium periodate (60).
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The most sensitive assay for TCGF Is simply a H-thymidine up­
take experiment using T blast cells which are transformed with PHA 
(55). After transformation* these cells are no longer responsive to 
PHA. They are, however, sensitive to TCGF, and are used to detect 
Its presence.
Other workers employ a co-stlmulator assay In which the mitogen 
is added (at suboptlmal concentrations) simultaneously with purported 
TCGF-contalnlng supernatant fluids to PBL (62). This results In 
greater Incorporation of the radiolabeled thymidine than with the 
mitogen alone.
TCGF was readily isolated from supernatant liquids of PHA- 
stlmulated human lymphocytes by ammonium sulfate precipitation (63). 
The concentrate was then applied to a DEAE-Sepharose column and 
eluted with sodium chloride. The active fractions were pooled, 
concentrated by ultrafiltration and then subjected to molecular 
sieve chromatography using Ultragel AcA54. TCGF eluted from the 
anlon-exchanger In 0.07 M NaCl and had an apparent molecular 
weight of 23,000. The active moiety was sensitive to trypsin 
digestion while deoxyubonudease (DNAase) and rlbonuclease (RNAase) 
had negligible effects.
It is apparent then that lymphokines In all likelihood perform 
an Immunoregulatory function during an Immune response. Indirect 
evidence for this phenomenon stems from Investigations of soluble 
suppressor substances of Immune origin.
Using supernatant fluids derived from transformed lines, Vesole 
et al. (64) noted that both mltogenlc and suppressor activities were 
present In the same supernatant preparation but that separation of
Che two molecules by gel filtration was required to detect mltogenlc 
activity In the bloassay. This was apparently due to the masking 
effect of the suppressor. Similarly, It was suggested by Wolf et 
al. (65), and later confirmed by Warren et al. (66) that tonsil 
lymphocyte culture fluids contained both suppressive and T cell 
growth factor activity.
The remainder of this discussion will consider various suppres­
sor factors and their roles In the Immune response. A rather broad 
spectrum of molecules has been Implicated as suppressors of cellular 
proliferation (DNA synthesis) of Immunocompetent cells. These 
Include prostaglandins, serum derived Immunosuppressive factors, 
leukocyte extracts, complement-related factors, low density lipopro­
teins, ct-l-acld glycoprotein, and lymphokines.
Prostaglandins, particularly the and E2 series, were shown 
to Inhibit the expected response of PHA-stimulated mononuclear cells 
(67). The suppression was noted In cultures containing glass- 
adherent cells and was ablated upon treatment with indomethacin, an 
Inhibitor of prostaglandin synthetase, or by dialysis of the super­
natant fluids.
Rice (66) reported a prostaglandin suppressor system which 
suppressed T lymphocyte proliferation. The factor was resistant to 
corticosteroids and did not depend on cellular division for Its 
production. Baker et al. (69) showed that PGEp and PGE,j reduced 
proliferation of differentiated cytotoxic T cells harvested from 
T cell growth factor-dependent cultures by 43%.
Human leukocyte extracts obtained by freeze-thaw lysis were 
growth inhibitory for a transformed B cell line and mitogen-treated
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peripheral blood lymphocytes. The suppressor was dlelyzable through 
3500 molecular weight cut-off tubing and may have been similar to 
prostaglandins (70).
There have been several reports of serum components which Inhi­
bited proliferation of activated lymphocytes. Low density lipoprotein 
(LDL) extracted from human serum was shown to Inhibit PHA- or poke 
weed mitogen (PWM)-stimulated FBL and PBL In mixed lymphocyte cultures 
(71). The LDL had an apparent molecular weight of 2-3 x 10® and 
contained 20-55% protein and 75-80% lipid. The molecule migrated 
electrophoretlcally In the 3 range and had a buoyant density of 
1.055 g/ml In potassium bromide. There was no loss of viability, . 
and the suppressive effect waB evident Irrespective of mitogen 
concentration.
Normal human plasma was shown to Inhibit lymphocyte stimulation 
by PHA at suboptlmal (>1 Pg/ml) concentrations (72). The suppressor 
was non-dialyzable and stable when heated at 56° C for 30 mln. It 
was further shown that the plasma bound directly to PHA since delay 
in adding the plasma to the PHA cultures reversed the effect.
Habict et al. (73) found that pooled human o-globulln fractions 
(Cohn IV and V) suppressed the plaque-forming-cell (B lymphocyte) 
response In mice. The material was partially sensitive to trypsin 
and contained llpld and/or carbohydrate moieties. The molecular 
weight was determined to be 10,000-50,000. Isoelectric focusing 
revealed four peaks of suppressive activity and three peaks of 
enhancing activity. This was confirmed by the dose response in which 
both activities were revealed In a single preparation.
Nelken et al. (74, 75) isolated normal Immunosuppressive protein
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(HIP) from the a-globulin fraction of scrum of 24 hr whole blood.
This glycoprotein was shown to Inhibit T cell and B cell DNA 
synthesis, EL-4 tumor growth, and antibody-dependent cell-mediated 
cytotoxicity. The material was 10,000-25,000 In molecular weight 
and was resistant to boiling. The factor was not species specific, 
had no effect on fibroblasts, and acted by a non-cytotoxic mechanism.
Benson et al. (76) also Identified a serum protein which sup­
pressed a B cell response, the antibody response, to sheep red blood 
cells. The suppressor was labile at 56° C for 30 mln and was absor­
bed by Immune complexes. The factor was shown to be or com­
plement components but not C2, C^, or Cg.
a-l-Acid glycoprotein (orosomucold), a serum protein produced by 
the liver, was Bhown to be elevated during stress and pregnancy, concen­
trated around sites of Inflammation, and found In Individuals with neoplasia. 
Orosomucold suppressed the response of mouse spleen cells to PHA,
con A, LPS, the antibody response to sheep red blood cells, and cell-
mediated cytotoxicity (77). The carbohydrate content of the protein 
was 45% of the weight of the Intact molecule and was necessary for 
expression of biological activity.
The concentration of C-reactlve protein (CRP) was found to be 
Increased In the acute stages of Inflammation, particularly In.pleural 
effusions (78), CRP inhibited ^H-thymidine Incorporation by lymphocytes 
stimulated In mixed lymphocyte culture, diminished the response of PPD, 
and caused a decrease in the production of migration Inhibitory factor 
(MIF). It was postulated that CRP may modulate the cell-mediated immune 
response and may contribute to anergy I.e. unresponsiveness to antigen 
insults associated with inflammation.
By far the most prevalent suppressors are proteins derived from
cells of the Immune response. Larsson et al. (79* 80) demonstrated
the existence of a factor produced by PHA-stlmulated PBL which
Induced macrophages to become suppressive to PPD-stimulated PBL.
Green et al. (81) using PHA-stlmulated lymphocytes found a
factor which Inhibited the growth of a variety of transformed cell
lines. Proliferation inhibitory factor (PIF) was non-dlalycable,
non-sedimentable at 90,000 x g for one hr, sensitive to trypsin, and
stable at 85° C for 30 tnln. The suppressive effect behaved in a
dose-dependent manner, caused no loss of viability of target cells,
«
and was reversible when the target cells were removed from PIF- 
contalnlng media before 24 hrs.
A factor produced by T cell-enriched lymphocytes stimulated with 
Insoluble con A was described by Williams et al. (82). The factor 
suppressed the mixed lymphocyte culture response without loss of 
viability. The activity was sensitive to chymotrypsin treatment, 
non-dlalyzable, partially labile at 56° C for 30 mln, and sensi­
tive to pH 2.0 after 24 hrs. Treatment with neuraminidase resulted 
in 15% loss of biological activity. It was probable that this factor 
was an a-lymphotoxln since antibodies directed against this family 
of lymphotoxlns ablated the suppressive effect.
Other workers (83) have shown that treatment of PBL with con A 
resulted in the elaboration of a substance suppressive for the mixed 
lymphocyte culture and for cell-mediated lympholysis. It was also 
demonstrated that the suppressive effect was mediated by macrophages. 
It was non-cytotoxlc, and did not require cellular division for the 
expression of activity,
Shou et al. (84) used PHI. grown four days In culture without
userum or any stimulatory agent to produce a suppressor of con A- 
stimulated PBL and mixed lymphocyte cultures. The suppressive 
material was stable at 56° C for 30 minutes, partially denatured at 
70° C for 30 minutes and destroyed at 80° C for 30 minutes. The 
active moiety was non-cytotoxic.
Two soluble immune suppressor substances (SISS) were Identified 
In PBL cultures stimulated with PllA or con A (85, 86). SISS-T was 
shown to Inhibit T cell mitogen and antigen responsiveness non- 
cy totoxically. The material wbb 30,000-45,000 d in size and was blocked 
i.e. activity by H-acetyl-D-glucosamlne. SISS-B Inhibited polyclonal B 
cell activation (i.e. immunoglobulin production) noncytotoxically.
The suppressor was inhibited by L-rhamnose. The apparent molecular 
weight of SISS-B was 60,000-80,000 and was stable at pH 2.5. Both 
factors were heat labile at 56° C for 30 minutes.
Another soluble suppressor factor (SSF) produced by pokeweed 
mitogen-stimulated PBL was found by Hoffman et al. (87). The 
factor was dependent on the presence of the macrophage for production. 
SSF was shown to inhibit MLC, T cell cytotoxic activity, and the 
generation of killer cells. It was further noted that the suppressor 
had to be present at the Initiation of culture for activity to be 
expressed.
An inhibitor of DNA synthesis (IDS) was suggested by Jegasothy 
et al. (68), IDS was produced by con A-stlmulated PBL in 48 hrs and 
inhibited PHA stimulation of PBL. The factor was glycoprotein in 
nature with the requirement of Intact carbohydrate moieties for 
biological activity. The suppressor appeared as a 20,000 d monomer, 
but It was also found as a dimer, trimer, and tetramer in solution.
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IDS was sensitive to trypsin and periodate. It was heat stable at 
60° C for 30 min, had an apparent pi of 3.4, and was non-cytotoxlc 
for target cells.
Another soluble Immune response suppressor factor (IRSF) 
produced by non-adherent, unstimulated PBL was reported (Lederman 
et al.), IRSF suppressed PHA, PHM, and con A stimulation of PBL.
The activity was partially dlalyzable, stable at 56° C for one hr, 
and Its production was unaffected by indomethacln.
Mixed lymphocyte cultures also were shown to produce a soluble 
factor which suppressed cytotoxic lympholyslB and mixed lymphocyte 
culture responses (90). The production of the active moiety was 
dependent upon the presence of antigen-sensitized lymphocytes and 
required restlmulatlon of those primed lymphocytes in the primary 
MLC.
Tibbetts et al. (91) used a nitrogen bomb to lyse PBL and found 
that the cell extract comprised suppressive material which Inhibited 
PHA stimulation of PBL noncytotoxically, mixed lymphocyte cultures, 
and growth of the transformed B cell line PGLC-33H. The suppressor 
was DNAase resistant, trypsin sensitive, stable at pH 5.4-B.4, and 
had an apparent molecular weight greater than 100,000*
By separating tonsil lymphocytes on an albumin gradient, Wolf 
et al. (65) demonstrated that a subpopulation of T lymphocytes 
stimulated with PHA could suppress PBL mitogen responsiveness. 
Furthermore, It was noted that the suppressive substance was produced 
constltuitively In tonsil T cells. The factor eluted predominantly 
In the exclusion volume of Sephadex G-100 and was resistant to heating 
at 60° C for 15 min.
Several Investigators used lymphoblastold cells as a source of 
soluble Inhibitors of mitogen-stimulated PBL. Green et al. (92) gen­
erated crowded lymphoblast culture supernatant fluids and subjected 
them to Ion exchange chromatography. The suppressive fraction was 
nan-dialyzable with an apparent molecular weight of 40,000-70,000.
The material was stable at 56° C for 30 min but thermolablle at 80°
C for 30 min. It was resistant to neuraminidase, and sensitive to
pronase and to pH below 2.4. The suppression occurred without
cytotoxic effects on target cells.
Hersch et al. (93) Identified a suppressor which possessed the
same characteristics as the factor described above. It was shown to 
be DNAase, RNAase, and trypsin resistant In addition to being pronase 
sensitive. Production of the Inhibitor was blocked by puromycln, 
cyclohexamlde, actinomycin D, arablnosyl-6-mercaptopurine, and arabl- 
nosyl cytosine. This Indicated cellular proliferation and protein 
synthesis was required for Its expression. It was postulated that 
crowding of the lymphoblasts resulted In contact inhibition by pro­
duction of an inhibitor via protein synthesis.
Other Investigators have found transformed cell culture super­
natants to comprise suppressor molecules. Using human B cell lines 
(SWB-16, RPMI-1788, RPMI-6410) and one T cell line (CCRF-CEM),
Vesole et al.(94) Identified a soluble Inhibitor of PHA-stlnmlated 
lymphocytes. The active moiety co-eluted with albumin on Sephadex 
G-100 and was reported to have two active lsoelectricfocuslng 
fractions at pH 2.99-3,55 and 4.35-4.55.
An Inhibitor produced by transformed cell lines derived from 
non-lymphoid tissue was noted by WerkmelBter (95). The soluble
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material whb shown to Inhibit FHAt PWM, MLC responses as well as de­
crease immunoglobulin production In a dose dependent manner.
As documented by the preceding literature review, there are a 
myriad of mltogenlc proteins and suppressor proteins which are produced 
by and/or affect lymphocytes. Until the advent of monoclonal antibodies 
specific for lymphocyte cell surface antigens, it was Impossible to 
determine precisely the cell population responsible for producing the 
various lymphoklne activities. This discovery coupled with fluorescent 
activated cell sorting has lead to the identification of at least two
•f _
distinct T lymphocyte subpopulatlons, TH4 and TH^ . It has been 
shown that the T helper subpopulation (TH^+) produces TCGF. Although 
there Is no direct evidence available, It is presumed that the suppressor 
cell subpopulation (TH^~) produces soluble suppressor factor(s). 
Furthermore, It Is known that tonsil lymphocytes contain the suppressor 
subpopulation in question and, therefore, it is probable that these 
cells produce a soluble factor capable of inhibiting the proliferative 
response of PBL to mitogens or antigens.
This report presents evidence which suggests that tonsil cell 
culture supernatant fluids comprise substances which are suppressive and 
stimulatory for allogeneic PBL.
OBJECTIVES
A major obstacle la lymphokine research Is obtaining enough 
homogeneous material for biochemical analysis. Initially, It was 
thought that tonsil lymphocytes would provide a large and readily 
available source for human lymphocytes and that, when stimulated 
with mitogens, these cells would produce substantial quantities of 
HLMF. It was found, however, that tonsil cells were not only 
undergoing blastogenesls without in Ditto stimulation, but that 
these cells, grown without serum or in vitro stimulatory agents, 
constltultlvely produced three discreet soluble factors which 
affected the proliferation of allogeneic PBL in different ways.
Since there were different activities present In the same 
supernatant fluids, was It possible that the factors were involved 
In regulating cellular proliferation of immunocompetent cells?
In order to address this problem, It was necessary to obtain purified 
material of each active moiety for the purpose of biochemical 
characterization. This report describes our observations and 
presents biochemical data defining some molecular parameters of 
a suppressor factor, and two mitogenic factors.
CHAPTER 2 
MATERIALS AND METHODS 
Preparation of Tonsil Cell Culture Supernatants. Palatine tonsils 
were removed from 3-16 yr old patients undergoing elective surgery for 
recurrent tonsillitis. The surgery was performed at least two weeks 
post-lnfectlon. The organs were placed Immediately In Ice cold RPMI- 
1640 medium (Flow Laboratories) supplemented to triple strength (3X) 
with penicillin (300 U/ral), streptomycin (300 pg/ml) (Grand Island 
Biological Co.), gentamycln 100 Mg/ml) (Sigma Corp.), fungisome 
(2 yg/ml) (Grand Island Biological Co.), and HEPES (25 mM) (Fig. 1) for 
transport from the hospital to the laboratory. Within two hr, the 
tissue was sliced In the laboratory Into small sections and gently 
pressed through a fixed 80-mesh screen (Cellector: E. C. Apparatus
Co). The cells were collected In a petrl dish containing 30 ml of 
supplemented RPMI-1640. After centrifugation at 50 x g for 10 min to 
remove the large debris, the mononuclear cells were separated by flo­
tation on Ficoll-Paque (Pharmacia Fine Chemicals) and counted on a 
hemacytometer. Tonsil cell preparations with less than 85X viability, 
as determined by trypan blue exclusion (96), were not used. The cells 
were adjusted to yield a final concentration of 4-5 x 10** viable 
cells/ml In RPMI-1640 supplemented with penicillin (100 U/ml), strepto­
mycin (100 pg/ml), and gentamycln (40 pg/ml) (IX). These primary 
cultures were Incubated in Coming 150 cm^ tissue culture flasks 
(Corning Glass Works) for 24 hr in 95Z air-SZ COj at 37° C.
Culture samples were examined for the presence of bacteria by the 
gram stain, and by growth on blood agar plates or In thloglycollate 
solution. Sabouraud's agar plates were used to test for the presence 
of yeasts. Contaminated cultures, which were rare, were discarded,
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Figure 1. Scheme for preparation of tonsil cell 
supernatant cultures.
Tonsil placed In 
ice cold (3X) RPMI-1640
\saBedTissue teah  apart; 
Pressed through 80 mesh screen 
Into 30 ml (3X) RPMI-1640
iCentrifuge 50 x g 
to remove debris
tired
00
1
Supernatant layer  on Ficoll-Paque; 
centrifuged 4  x g for 40 min
Mononuclear fraction 
removed by .aspiration
t'ashed XCells wash  2 
in 3 X RPMI-1640
Final pellet suspended 
to 4 x 10  ^viable cells/ml 
in serum-free C1X) RPMI-1640
fIncubate 24 hrs at 
37° C in 95X air-5X C02
Cultures terminated 
by centrifugation
Supernatant Lyophilized 
Rehydrated in.small volume
7 1 • - 1 “
Supernatant: dlalyzed 
against 0.05 M MH^HCO^ pH 7.3
Lyophilized
IStored -80° C
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The cultures were terminated by centrifugation at 400 x g for 10 min. 
The supernatant fluids were then concentrated by lyophlllzatlon end 
centrifuged at 100,000 x g for 1 hr at 10° C In a 35 TI (Sorvall) 
rotor to remove Insoluble matter. These supernatants were frozen, 
or dialyzed against 0.05 M NH^HCO^ solution, pH 7.3, and lyophilized 
in both instances, the samples were stored at -85° C. Prior to 
testing for activity In the bioassay, lyophilized Bupematants were 
rehydrated In5.0 ml of phosphate-buffered saline (PBS: 0.15 K NaCl, 
0.0076 M Ha2HP0 ,^ 0.0024 M Na^PO^; pH7.2) and dialyzed againBt the 
same buffer to remove residual ammonia. They were finally dialyzed 
in supplemented (IX) RPMI-1640.
Bloassays. Blood was obtained In heparlnized (10 U/ml) syringes 
by phlebotomy of normal adult humans. The lymphocytes were prepared 
by flotation on Flcoll-Paque (Fig. 2). The mononuclear cell layer 
was removed by aspiration, and the cells were washed three times 
with Hank's balanced salt solution. Recovery of washed cells was 
accomplished by centrifugation at 400 x g for 10 min. The washed 
cells were suspended In a small volume of RPMI-1640, and viability 
was determined by trypan blue exclusion.
The PBL were adjusted to 2 x 10*> viable cells/ml in supplemented 
RPMI-1640 made 20% with human AB+ serum (Flow Laboratories). Assays 
were done In sextuplet (unless otherwise noted) In flat-bottomed 
96-well Falcon Micro Test II sterile tissue culture plates (Becton- 
Dlckenson and Co). Each well received 0.1 of the cell suspension, 
and 0.1 ml of tonsil cell culture supernatant which had been dialyzed 
against supplemented RPMI-1640 and fdlter-sterlllzed with a 0,22 ym
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Figure 2. Suppressor/augmentor and mltogenlc 
factor bloassay protocols.
PBL Isolated 
on Ficoll-paque 
and waBhed X 2
IUSpiCell suspended 
to 4 x 10® viable cells/ml 
In RPMI-1640 with 
20% AB+ serum
0.1 ml of cell suspension 
0.1 ml of tonsil supernatant 
added to micro culture wells
Suppressor/Augmentor 
Control: 0.1 ml RPMI-1640 
0.1 ml cell suspension
10 pg/ral Con A added 
(25 pi) to each well
/
\
Mitogenlc Factor 
Control: 0.1 ml RPMI-1640, 
0.1 ml cell suspension
Incubated 72 hrs 
at 37° C in 95%-5%
\1 uCi 3H-thliC ymidine; 
Incubated 12-15 hrs
I
Assay harvested 
on MASH II with 
glass fiber filters
I
piFilters laced in 
plastic minivlals 
with 4.0 ml Sclntlsol 
and counted
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filter (Gelman Sciences) before being used in the bloassey.
Suppression and augmentation were determined by the ability of 
the tonsil cell supernatants to reduce or augment the Incorporation 
of H-thymidine by the PBL upon addition of con A to the wells. Con 
A (Mlles-Yeda) was suspended in a solution of 1 M NaCl and 10 M 
MgC^, CaClji and MnCl2 < The concentration of the con A In the 
stock solution was 750-800 pg/ml as measured by Its optical density 
(E^qq 13). The stock was diluted to 80 pg/ml with supplemented 
RFMI and 25 pi were added to each well for a final concentration of 
10 pg/ml. The plates were Incubated three days at 37° C In 952 air- 
52 C02 before the addition of 1 pCl (6 Ci/mMole). The cultures were 
Incubated another 12 hr, and then harvested with a HASH II (Micro­
biological Associates). The glass fiber filters (Whatman 934 AH 
or GF-C) were dried, placed in plastic mlnl-vlals containing 4,0 ml 
of Sdntlsol (Isolab), and radioactivity waB determined in a Beckman 
3155T Scintillation Counter pre-set at 1.02 error. Background counts 
per minute with vials containing Sclntlsol were 25 ± 5. The controls 
were cells cultured with medium made 202 in AB+ serum, with and without 
con A, in the absence of supernatant fluid. Counts per minute and 
standard deviations (n ■ 6) were recorded.
After determining radioactivity, suppression wsb calculated 
using the formula:
2 Suppression - (1 - cPm suppression supernatant ) X 100
cpm con A-stimulated control
Target cell viability was examined by the trypan blue exclusion 
method (96). In some cases, trypan blue was added directly to the
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tnlcroculture wellB Just prior to termination of the bloossay.
Augmentation was calculated using the formula:
X Augmentation * ( cPm augmentation supernatant x ^qq
cpm con A-Btimulated control
In experiments measuring mitogenlc activity, the same assay was 
employed but con A was absent from the wells. The mitogenlc Index 
(M.I.) was then calculated by the formula:
M. I. * cpm of tonsil supernatant 
cpm of AB+ serum control
Primary Culture Blastogenesis. PBL and tonsil lymphocytes were 
tested for their ability to Incorporate ^H-thymidine in the absence of 
in vitro stimulation. Lymphocytes Isolated by flotation on Flcoll- 
Paque were suspended In supplemented (IX) RPMI-1640. Concentrations 
of 4 x 10® cells/ml were used. Aliquots of 0.2 ml of the cell 
suspension were added to flat bottom microculture plates. The cells 
were Incubated for 24 or 48 hr at 37° C In 95% air-5% CO2. Twelve hr 
prior to harvesting the assay 1 yCi of H-thymidine (6 Cl/mmole) was 
added. The assays were done In sextuplet. The cells were harvested 
and the Incorporation of radioactivity was done as described earlier. 
Protein was determined by the modified Lowry method (97).■
Dose Response. Lyophilized tonsil lymphocyte supernatant fluids 
were rehydrated with PBS to give a 16-fold concentration of the 
original supernatant volume. Serial dilutions were made In supple­
mented RPMI-1640 which then were assayed for suppression as described.
Supernatants which had augmenting and mitogenlc activity were 
rehydrated in PBS to a concentration of 60-fold. Serial dilutions
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were made in supplemented RPMI-1640 and then assayed. Protein was 
determined using a modified Lowry method (97)•
Statistical Analysis. To determine the statistical significance 
of suppression or augmentation, the difference between means of 
test supernatant and control supernatant ± 95% confidence limits about 
the difference was calculated. The confidence limits were constructed 
using Dunnett's Q* (98) statistic and the standard error of the 
difference used to establish the limits was computed from the error 
mean square of a one-way analysis of variance (ANOVA).
The fit of dose response data for mitogenicity and augmentation 
to a straight line was estimated by least square linear regression.
When individual comparisons were made between experimental 
and control values, Dunnett's test was used (PL.05).
Trypsin Sensitivity. Immobilized trypsin (1238 U/gi Millipore 
Corporation) was washed repeatedly in several volumes of 0.1 M Tris- 
HC1 solution, pH 8.0. Concentrated supernatants with biological 
activity were dialyzed against the same buffer. A small aliquot of 
each dialyzed supernatant was reserved to serve as control, and the 
remainder was treated with 50 pg of the washed enzyme for 1 hr at 
room temperature. The reaction was terminated by the addition of 10 
pi of dilsopropylphosphofluorldate (DFP) (.054 M). Each sample then 
was centrifuged at 100 x g to remove the immobilized trypsin and 
the supernatants were dialyzed against PBS to remove unreacted 
DFP.
Gel Filtration Chromatography. Concentrated crude suppressor- 
active supernatant fluids were fractionated using columns (1.5 x 
90 cm) of Sophadex C-100 (Pharmacia Fine Chemicals), The gel
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matrix waa equilibrated with NH^HCOj (0.05 M, pH 7.3). Aliquots of 
100 pg of 60 X concentrated supernatant material were weighed out and 
rehydrated In 2 ml of PBS, dialyzed against the ammonium bicarbonate 
buffer and applied to the column. Fractions of 2 ml were collected 
and their protein content determined by OD2go> The fractions were 
pooled as shown In Fig. 5, lyophilized, rehydrated in PBS and dialyzed 
against supplemented RPMI-1640 In preparation for blbassay. The 
column was calibrated with the following molecular weight standards: 
bovine serum albumin (mol wt 68,000), carbonic anhydrase (mol wt 
29,500) and myoglobin (mol wt 17,200). Blue dextran (0.12) waa used to 
determine the exclusion volume.
Isoelectric Focusing. Preparative isoelectric focusing was done 
using Ampholytes 3-10 (LKB) or Pharmalytes 3-10, 4-7, and 5-8 
(Pharmacia Fine Chemicals) with Ultradex (LKB) serving as the support 
medium.
Supernatant fluids exhibiting suppressive activity In the 
bloassay were concentrated by lyophlllzatlon, rehydrated In PBS to 
a final concentration of 60 X and then dialyzed against 12 glycine 
solution pH 7.2. After dialysis the experimental sample was mixed with the 
gel slurry. Plates 3 mm in depth were prepared and allowed to dry 
to the evaporation limit at room temperature. The gels were then 
focused at 10° C using an LKB multiphor apparatus. Electrophoresis 
was at 8 watts constant power until no further drop in mllliamperage 
could be detected. A control gel incorporating an identical mixture 
of Pharmalytes and Ultradex but containing no protein was treated 
under the same conditions.
The pH gradient was determined using an LKB Multlphore electrode.
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The gel bed then was cut Into 12 equal sized sections. Each was placed 
In a plastic funnel and eluted with 3-5 ml of deionized water. To re­
move residual Pharmalytes, the eluates were dialyzed against PBS. Poly­
ethylene glycol 6000 (Eaatman Kodak Co) was Included in the dialysis 
buffer to help stabilize protein. The protein content of each fraction 
was determined by 0D2qq on a Carey 219 Spectrophotometer (Varlan) or by 
a modified Lowry technique (97). Nucleic acid was measured by ODjgo.
The eluates finally were dialyzed against supplemented RPMI-1640 and 
subjected to the bloassay.
Ion-Exchange Chromatography. Anion exchange resin DE-52 (Whatman) 
was equilibrated in tris-HCl buffer (40 mM, pH 7.2; start buffer) and 
columns 0.9 x 15 cm (packed gel) were prepared with the pressure head 
aet at 30 cm. Aliquots of 1.0 ml (200 pg) of concentrated supernatants 
having suppressive or augmenting activity were dialyzed against the 
starting buffer and then layered on the gel. The column was washed with 
two volumes (20 ml) of starting buffer before beginning the linear 
gradient of 1 M NaCl. The elution rate was 20 ml/cm^/hr.
Conductivity of the 2-ml fractions was determined using a conduc­
tivity meter (Radiometer CDM 2) and each fraction was examined for total 
protein OD220 or nucleic acid by OD260* A small aliquot of the crude 
preparation was used for comparison purposes. Fractions were pooled as 
indicated in RESULTS, dialyzed against PBS, and lyophilized. The dried 
material was rehydrated with deionized H2O In a small volume and dia­
lyzed first against PBS, to remove salt and then against supplemented 
RPMI-1640 in preparation for bloassay.
To determine specific activity of the suppressive material, 
several supernatants were separated by anion exchange chromatography.
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Preliminary data Indicated the 0.4 M to 0.6 M fraction to contain 
suppressive material; therefore, this fraction was used in the 
bloassay. An aliquot of the crude preparation was tested simulta­
neously with the partially purified material.
Protein was measured by 0D2qq. Specific activity (S. A.) was 
then calculated by:
S. A. - % Suppression
O.D.20O units
Immunoelectrophoresis. Commercially prepared agarose Immuno­
electrophoresis plates equilibrated with sodium barbitol (pH 8.6, 
ionic strength 0.05) were used to examine culture supernatant for 
the presence of human immunoglobulins and a2-macroglobulin. Tonsil 
cell supernatants that demonstrated a suppressive effect in the 
bloassay were lyophilized and rehydrated in PBS to give a 120-fold 
concentration with respect to the original supernatant volume. A 
small aliquot wsb dialyzed against the barbitol buffer Just prior to 
use. Volumes of 50, 100, 150, or 200 pg were added to the wells and 
electrophoresis was carried out using a Corning 700 electrophoresis 
Power Unit for 30 min. Pooled human AB+ serum served as a 
control.
Pooled goat antisera to human IgG, IgA, IgE, IgM, and commercially 
prepared (Cappel Laboratories) a2-macroglobulln antisera were added to 
appropriate troughs and allowed to diffuse overnight. Residual 
antibody was removed by soaking the plate in PBS. The plates were 
stained with thlazine red (12), destalned in acetic acid (52), and 
photographed.
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Temperature Sensitivity. Suppressor-active supernatants were 
tested for thermal stability at 56° C for 30 min, 80° C for 10 min, 
and 100° C for 5 min. Aliquots of 0.5 ml of concentrated (60 X) 
material rehydrated in PBS were placed In 1-ml pyrex test tubes 
with stoppers. Bach sample was placed In water bath set at the 
appropriate temperature. After the sample had reached the appropriate 
temperature, timing was begun. The samples were removed, dialyzed 
against supplemented RPMI-1640 and assayed for suppressor activity.
Polyacrylamide Gel Electrophoresis. Standard alkaline gel 
electrophoresis was done as described by Brewer et al. (99).
Acrylamide (Bio-Rad Laboratories) gels 6.5 mm containing 7.5% TEMED- 
polymerized acrylamide were cast in 0.7 x 8 mm glass tubes. A 
solution of 3.75% acrylamide was layered on top and photopolymerized 
with riboflavin (Bio-Rad Laboratories) to form stacking gels.
Aliquots of 50-100 pi of the 60 X concentrated crude suppressor
preparation or the 0.5 M-0.6 M anion exchange fractions were
dialyzed against the electrophoresis buffer (trls, 5 mM; glycine,
38 mM; pH 8,9) and applied to the gels with an Adams suction apparatus
(VWR Scientific, Inc). Sucrose was included In each sample to final
concentration of 10%. Human serum albumin (100 pi of 500 pg/ml),
|
pooled AB serum (10 pi of 100%) and ovalbumin (100 pi of 500 pg/ml) 
were used aB controls.
The gels were electrophoresed In trls-glyclne buffer at 1.0 mA 
per tube until the dye exited the stacking gel. Then the current was 
Increased to 1.5 mA for the remainder of the electrophoresis.
Gels were stained for protein by one of the following methods:
(1) Formaldehyde-Coomassle Blue (100). Proteins were fixed and stained
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for 3 hrs in 700 ml of an aqueous solution of ethanol (242 u/v) and 
formaldehyde (52 v / v )  containing 0,8 gm of Coomassle Brilliant blue 
R-250 (Eastman Kodak Co). Destalnlng was affected with an aqueous 
solution of ethanol (772 v / v )  and formaldehyde (12 u/u) overnight 
In a gel electrophoresis diffusion destalner (Bio-Rad Laboratories).
(2) Periodic acld-Schlff reagent (PAS). Glycoproteins were sought 
by a PAS technique (101). The protein was fixed In 12.52 trichloroacetic 
add solution for 1 hr, and oxidized with 12 periodic acid solution 
for 2 hr. The gels were washed In 152 acetic acid for 2 hr and then 
reacted with Schlffs Reagent (Fisher Scientific) for 2 hr at 4° C 
In the dark. Destalnlng was with 152 acetic add. Ovalbumin served 
as a control for the PAS method.
Stained gels were photographed with a Minolta X D 35 mm camera 
(Minolta Corp) containing Plus X Pan 125 black and white film 
(Eastman Kodak, Co). A light orange filter (Tiffen Inc) was placed 
over the lens to help reproduce the lighter staining bands.
Chromatofocuslng. Suppressor active supernatants were fraction­
ated by chromatofocuslng. The concentrated crude preparation was 
dialyzed against a start buffer of 0.025 MM lmldazole-HCl, pH 7.4 
overnight at 4° C.
Chromatographic columns (9 mm x 15 cm) were fully packed with 
PBE-94 (Pharmacia Fine Chemicals) and the gel beds equilibrated with 
several column volumes of start buffer until the eluted buffer 
registered pH 7.4.
Polybuffer 74 (Pharmacia Fine Chemicals), was titrated to pH 4.0 
with 0.5 N HC1, diluted (1:8) to the appropriate volume, and the pH 
readjusted to 4.0. Five ml of the eluent buffer was run onto the
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column and then 0.5 ml of the dialyzed supernatant was applied.
The elution was continued with the polybuffer using a pressure head 
of 30 cm.
Fractions of 2.0 ml were collected until no further drop in the 
pH could be detected. The fractions then were combined Into six 
pools of equal volume. The pools were placed In dialysis tubing 
with a 14*000 molecular weight exclusion limit (Spectraphor) 
and dialyzed against two* four liter volumes of 0.05 M NH4HCO3, 
pH 7.2 overnight at 4° C. The material was lyophilized* rehydrated 
with PBS to 0.5 ml* dialyzed against PBS and then supplemented (IX) 
RPMI-1640 before bloassay.
In one experiment* the pools were concentrated by Amicon filtra­
tion In a step wise fashion. The pools were first concentrated on a 
YM 50 membrane (Amicon Corp) followed by reconcentration of the eluate 
on a YM 10 membrane. The retentates of each filtration were washed 
repeatedly with PBS until the pH of the filtrate was equivalent to 
the buffer. Both the 50*000 and 10*000 retentate fractions of 
each pool were assayed following dialysis against (IX) RPMI-1640.
To determine the effects of non-dialyzable polybuffer consti­
tuents on the bloassay* a small aliquot of Folybuffer 74 was titrated 
to pH 4.0 and diluted (1:8) to the appropriate volume. The buffer 
solution was dialyzed as described above and assayed.
Separation of Adherent and Non-adherent Cells. To determine the 
cell population responsible for producing the augmentor* tonsil cells 
were separated into plastlc-non-adherent and plastic-adherent popula­
tions in the following manner. Tonsil cultures were Incubated for 
2 hr In plastic tissue flasks containing supplemented RPMI-1640 (IX)
under normal conditions. The non-adherent cell population was then 
decanted Into another flask and incubated for an additional 22 hr.
The adherent cells were reconstituted in fresh RPMI-1640 and Incubated 
for 22 hr. The control cultures were treated in the usual manner.
CHAPTER 3 
RESULTS
The Proliferative Activity of the Tonsil Cells. As shown in Table 
1, the amount of radioactivity Incorporated hy PBL in culture for 24 
hr or 48 hr was low, and typical of what was routinely accepted as 
"background" level for unstimulated PBL. Conversely, some tonsil 
lymphocytes showed greater than a tenfold higher incorporation of H- 
thymidine compared to that taken up hy PBL at 24 hr (Table 1). In 
addition, a significant decrease in actual cpm was observed at' 48 hr. 
The proliferative activity in a 24 hr period of tonsil lymphocytes 
from among the many tonsils studied varied widely, hut was usually 
greater than that of PBL. The number of proliferating cells in the 
population was not determined.
Effect of Tonsil Cell Culture Fluids on the Con A-Induced Pro­
liferation of Normal PBL. As demonstrated above the tonsil cell popu­
lation was in an activated state when compared to PBL. It was 
also found that supernatant culture fluids generated in the absence 
of in vitro stimulation of the tonsil cells often Inhibited the 
proliferative response of PBL to con A.
Tonsil cells were cultured in the absence of serum for 24 hr.
After recovery of the supernatant fluids, they were centrifuged at 
100,000 x g, to remove Insoluble particulate matter, and then tested for 
their effect on the incornoratlon of H-thymidine by PBL cultured 
with con A. The data are presented in Table 2. Of 29 different 
tonsil cell supernatants assayed, 24 significantly suppressed the 
Incorporation of ^H-thymldine by PBL cultured with con A. The extent 
of suppression ranged from approximately 22% to 84% with the average 
being 43%, Five of the tonsil fluids had little or no effect on the
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TABLE X
Unstimulated Proliferative Activity in vitro 
of PBL and Tonsil Cells
Sample Incorporation of ^H-thymldlne*2
Number 24 hr 48 hr
PBLb
1 4,574 ± 714 1,350 + 524
2 1,177 + 130 1,235 ± 88
3 1,279 ± 284 1,350 ± 1,314
4 1,156 ± 371 1,463 ± 240
5 1,264 ± 427
Tonsil Cells^
1 13,940 ± 1,184 7,340 ± 604
2 7,631 1 494 4,330 ± 286
3 12,093 ± 1,227 10,545 ± 780
4 14,705 ± 1,196
5 11,399 ± 1,639
6 12,253 1 1,272
7 18,085 ± 2,481
8 9,265 ± 2,230
9 11,187 ± 1,640
10 9,964 ± 1,010
11 5,262 ± 535
12 21,596 ± 1,991
13 9,064 ± 642
14 9,383 ± 483
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TABLE 1
Unstimulated Proliferative Activity in vitro 
of PBL and Tonsil Cells (Cont)
Sample Incorporation of ^H-thymidinea
Number 24 hr 48 hr
Tonsil Celled
15 4,516 + 411
16 2,445 ± 390
17 5,120 + 759
18 3,029 + 668
19 9,288 ± 1,415
20 10,597 ± 1,100
21 1,937 ± 368
22 2,717 + 297
23 5,714 ± 960
24 3,656 ± 450
aCells were cultured in microculture trays without stimulation for 
24 hr or 48 hr. Twelve hr prior to harvest, 1 pCi ^H-thymidine was 
added to the wells.
^Mean cpm ± S.D. n - 6.
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TABLE 2
Effect of Tonsil Cell Culture Fluids on Transformation 
of Normal PBL Stimulated with Con Aa
Experiment Sample X
Number Number^ CPJ^ Suppression6 A Meon^* Signif. M
1 Con A° 107,021 + 12,022
1 74,023 + 22,846 31 -32,988 4 18,806 +
2 99,405 ± 7,327 7 - 7,616 ± 18,806 -
3 95,483 ± 14,103 11 -11,538 ± 18,806 -
4 95,803 + 8,818 12 -11,218 ± 18,806 -
5 95,128 + 9,405 11 -11,893 ± 18,806 -
2 Con A 79,793 + 14,494
6 61,909 + 6,940 23 -17,884 ± 20,098 -
3 Con A 54,660 + 7,515
7 35,578 + 4,875 45 -19,082 ± 8,108 +
8 41,441 + 2,901 24 -13,219 4 7,606 +
9 11,394 + 858 79 -43,266 ± 8,108 +
10 8,495 ± 1,397 84 -46,165 ± 8,108 +
4 Con A 100,067 + 6,745
11 60,765 + 8,570 39 -39,302 4 14,712 +
5 Con A 88,953 ± 1,631
12 34,251 4 3,464 61 -54,702 4 6,589 +
13 52,713 4 4,370 40 -36,240 ± 6,589 +
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TABLE 2
Effect of Tonsil Cell Culture Fluids on Transformation 
of Normal PBL Stimulated with Con Aa (Cont)
Experiment Sample 
Number Number^ CPf^ Suppression6 A Mean/' Sipnlf.^
Con A° 72,382 ± 3,982
14 39,783 ± 2,971 45 -32,599 ± 6,735 +
15 41,412 + 4,531 42 -30,970 ± 6,735 +
16 43,049 ± 6,523 . 40 -29,333 + 6,735 +
17 47,665 + 4,406 34 -24,717 ± 6,735 4"
Con A 47,249 + 21,180
18 22,802 + 2,855 52 -24,447 ± 5,169 4*
18 29,108 ± 3,517 38 -18,141 ± 5,421 +
Con A 132,621 ± 16,834
20 48,084 ± 11,442 64 -84,537 ± 24,745 +
21 39,236 ± 6,200 70 -93,385 ± 24,745 +
22 83,574 ± 15,289 37 -49,047 ± 24,745 +
23 89,868 ± 14,854 32 -42,753 ± 24,745 4*
24 104,069 t 18,105 22 -28,552 ± 24,745 4-
25 71,734 ± 5,267 46 -60,887 + 24,745 4-
26 103,933 + 9,847 22 -28,688 + 24i745 4-
27 92,531 ± 17,785 30 -40,090 i 24,745 4*
Con A 64,118 ± 13,646
28 48,828 ± 5,694 24 -25,289 ± 11,936 +
29 46,195 + 6,381 28 -17,923 ± 11,936 +
TABLE 2
Effect of Tonsil Cell Culture Fluids on Transformation 
of Normal PRI. Stimulated with Con Aa (Cont)
aTonsil cells were cultured in the absence of stimulation. The 
supernatants were assayed by their effect on PBL cultured in the 
presence of con A,
^Numerals refer to individual patients' tonsils.
ffCon A refers to radioactivity incorporated by PBL stimulated with 
con A in the absence of tonsil cell culture fluid.
^Mean cpra ± S. D. n « 6.
ePercent suppression of radioactivity incorporated by PBL stimulated 
with con A in the presence of tonsil cell culture fluid compared to 
that incorporated in the absence of tonsil cell culture fluids as 
described in text.
^The difference between means of test supernatant and control ± 95JE 
confidence limits about the difference.
^The error used to calculate limits was from analysis of variance. 
(+) indicates significant suppression.
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PBL target cells. In all experiments target cell viability was 90% 
or greater, regardless of the suppressive effect of the tonsil cell 
supernatant.
Suppressor supernatant fluids were examined for protein according 
to Lowry (97) and for primary culture blastogenesls (Table 3). From 
this, one might predict that an Increase in total protein would be 
accompanied by an increase in the primary culture cpra. However, when 
the measured parameters of supernatant fluids 9 and 10 were compared 
it was evident that, although they comprised approximately equal 
amounts of protein (Table 3), there was considerable difference in 
the degree of non-induced blastogenesls. Similarly, one would expect 
a concomitant Increase in total protein and suppressor activity or 
in the amount of blastogenesls in the primary culture and suppressor 
activity. This, however, was also disputed by the data. It was 
concluded, that there was no apparent relationship between total 
protein In the crude supernatant preparation and blastogenesls nor 
between protein and blastogenesls and suppressor activity.
Absence of Immunoglobulins and a2-Macroglobulin In Suppressor 
Supernatants. The tonsil cell supernatants were tested by Immuno­
electrophoresis for immunoglobulins (Fig, 3). There was no evidence 
for the presence of immunoglobulins G, A, M, E or a2-macroglobulin in 
suppressive supernatants. The visible patterns of the control lndlca-
A
ted the antiserum used was reactive towards the AB serum antigens.
Dose Response of Suppressor-Actlve Supernatant. The suppressive ef­
fect of various concentrations (8 ■ 1 mg) of supernatant fluid is illus­
trated In Fig. 4. The amount of suppression Increased as the concentration 
of the supernatant waB raised. In several experiments of this kind.
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TABLE 3
Comparison of Percent Suppression with Total Protein 
and Nan-Induced Blastogenesls of Primary Culture
Primary Culture Parameters Bioassay of
Protein Primary Culture
Supernatant Concentration Volume Blastogenesls Percent Suppression
Number (ug/ml)a (ml)fc (cpm)° (cpm)^
1 50 50 4,516 ± 411 11
2 90 250 1,937 ± 368 23
3 100 550 9,383 ± 483 12
4 115 150 9,064 ± 642 11
5 130 300 21,596 ± 1,997 7
6 150 167 29,285 ± 1,951 45
7 265 550 14,985 ± 1,755 36
8 300 550 7,967 ± 843 83
9 330 300 5,262 ± 535 31
10 330 600 7,373 ± 1,188 40
11 340 600 7,193 ± 871 44
12 380 200 9,993 ± 499 30
13 400 200 9,522 ± 466 18
14 420 350 11,629 ± 227 87
15 580 1,000 12,430 i 1,433 64
TABLE 3
Comparison of Percent Suppression witti Total Protein 
and Non-Induced Blastogenesls of Primary Culture (Cont)
aProtein concentration (pg/ml) in primary culture supernatant 
preparation as determined by Loury technique (97).
^Volume of original supernatant fluid (ml).
^cpm ± S. D. (n * 6) of non-induced blastogenesls of primary 
culture.
^Percent suppression*In bioasBay of primary supernatant culture 
fluids.
Figure 3. Immunoelectrophoresis of suppressor 
active supernatant preparations, Allgots of 5, 10, 
15, or 20 ul of pooled human AB+ serum (A, C, E, G) 
or 100, 150, 200 ug of concentrated crude suppressor 
supernatant fluids (B, D, F) were added to the wells. 
Fooled goat antisera to human IgG, A, M, F., and o2- 
macroglobulln were added to each troughs. The plate 
was developed as described in text.
AG
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Figure 4. Suppression of con-A activated PBL by 
different concentrations of tonsil cell supernatant. 
Concentrated crude preparations were serially diluted in 
RPM1 1640 (8 ■ 1 mg crude protein) and submitted to the 
suppressor/augmentor assay.
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It became apparent that a two-fold concentration usually produced 
significant suppression.
Thermal Stability of Suppressor-Active' Supernatants. Suppressor- 
active supernatants were tested for thermal stability at 56° C, 80° C, 
and 100° C. The results are shown In Table 4. The suppressor activity 
was partially denatured at 80° C for 10 mln while 100° C completely 
eradicated the activity. No loss of activity was noted at 56° C for 
30 mln (data not shown).
Effect of Trypsin. Immobilized trypsin completely destroyed the 
suppressive activity in four of the six active supernatants (Table 5), 
and about 67JK of the activity In another supernatant (No. 2) was 
destroyed. Only 26% of the activity of sample six was destroyed, 
however. These data suggested that suppressor activity was attri­
butable to protein.
Molecular Sieve Chromatography of Suppressive Material. Molecular 
sieve chromatography was used to Investigate the apparent molecular 
weight of the suppressor substance. The elution profile of concen­
trated suppressor culture fluid on Sephadex fi-100 Is shown in Fig. 5. 
The majority of suppressor activity eluted In the exclusion volume 
and corresponded to an apparent molecular weight >100,000 d (Fool 1).
A small amount of detectable activity was also noted In the 68,000 d 
range (Pool 2). Pool 5, as shown by hatching, contained augmenting 
activity and will be discussed below.
Ion Exchange Chromatography of Suppressor-Active Supernatant. 
Concentrated suppressor-active supernatant fluids were fractionated 
on columns of DE-52 equilibrated with SO niM tris-HCl at pH 7.2. A 
salt gradient of NaCl was used to elute the suppressor-active material.
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TABLE 4
Thermal Stability of Suppressor-Active Supernatants
X Suppression X Suppression after heating
Untreated 80° x 10 mln
87 55
40 15
64 42
44 31
100° x 5 mln 
38 0
35 0
29 0
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TABLE 5
The Effect of Trypsin on Suppressor Activity
Supernatant Humber cpM0
L
X Suppression
Con A Control 76,538 ± 6,199 -
Con A + Trypsin + DFP° 75,116 ± 2,038 -
1 31,967 + 3,548 56
i 77,113 ± 9,017 N^
2 43,318 + 6,522 43
2 T 65,721 ± 8,011 13
3 46,840 t 5,264 38
3 T 79,292 ± 2,664 NS
4 65,183 ± 8,991 13
4 T 76,012 ± 9,726 NS
S 40,734 ± 1,288 46
5 T 76,453 ± 2,851 NS
6 31,942 ± 3,030 58
6 T 43,627 ± 7,444 42
flCounts per minute ± standard deviation, n - 3.
X Suppression calculated using con A + trypsin + DPP control
value.
°DFP added to trypsin prior to addition of trypsin to con A control. 
^Trypsin-treated supernatant. 
eNot significant.
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Figure 5. Elution profile of tonsil supernatant fluids 
on Sephadex G-100. After equilibrating the gel in .05 M 
NH4HCO3 ptl 7.2* a 1.5 x 90 cm column was poured. An aliquot 
of 200 eg of the crude preparation was rehydrated in 1.5 ml 
of buffer and applied to the column. Fractions of two ml 
were collected, pooled as shown and concentrated by 
lyophllizatlon. The concentrated pools were rehydrated in 
RFMI-1640 and submitted to the suppressor/augmehtor assay. 
Percent suppression (pools 1 and 2), percent augmentation 
(pool 5), and ODjgg nm (•--•).
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Representative data from one of several experiments are shown In Fig.
6. They revealed that the significantly suppressive substance (Pool
6) adhered strongly to the anion exchanger and eluted In fractions of 
conductivity corresponding to 0.4 M to 0.6 M NaCl. Less than one- 
fourth of the total protein (as determined by OI^q) was found In the 
active fraction (Pool 6), but the activity present In this poo] 
comprised about one-half of the total bloactivlty.
Five supernatants were examined for protein (OD280) a°d suppression 
before and after fractionation on the anion exchanger. Specific 
activity was then determined as described. As shown in Table 6, 
four of the five supernatants tested had improved specific activity 
after elution compared to unfractionated preparations. The amount of 
actual increase in units of activity varied greatly with a range of 
6.3 to 459.
Polyacrylamide Gel Electrophoresis of Suppressor Active Super­
natant Fluids. Polyacrylamide gel electrophoresis was performed on 
the crude suppressor supernatant preparations and the hioactive 
anion exchange fraction. Control proteins were human serum albumin 
and pooled AB serum. There was considerable protein heterogeneity 
within each crude supernatant preparation. The observed pattern (Fig.
7) was noted repeatedly in several active supernatant fluids. There 
consistently were 7 or B stalnable bands visible in each gel.
Electrophoresis of the anion exchange fraction (Pool 6) revealed 
a single band lightly stained with Coomassle Blue. The protein 
migrated slightly faster than human serum albumin in a control gel.
Its mobility corresponded to that of a protein present in the 
unfractionated supernatant.
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Figure 6. Ion exchange (DE-52) chromatography of a 
suppressor active tonsil supernatant. The gel was equilibrated 
in with SO ram tris-HCl pH 8.2. 100 pg of lyophillzed
supernatant preparation was applied to the column and 
eluted with a linear salt (NaCl) gradient of 0 to 1 M.
Fractions of 2.0 ml were collected and prepared for bloassay 
as described. Fractions were pooled as shown by shaded areas. 
O.D.220 nm ’ conductivity (mMHO's » — ), shaded area
is percent suppression in bloassay.
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TABLE 6
Specific Activities of Unfractionated and Fractionated Suppressor Supernatants
OD280a
Unfractionated Supernatant 
Percent Suppression^*
Specific
Activity*1 OD280a
Ion Exchange Fraction 6 
Percent Suppression
Specific
Activity
1.79 21 12 .604 24 40
1.43 38 27 .608 20 33
1.43 44 31 .588 15 26
0.409 16 39 .186 30 161
0.117 58 496 .073 70 959
^0^280 spectrophotometric measurements before and after ion-exchange fractionation.
^Percent suppression calculated as described in text.
^Specific activity calculated by: S. A. * ? Suppression
“ 280
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Figure 7. Polyacrylamide Gel Electrophoresis of Active 
Supernatant Fluids
Polyacrylamide gel electrophoresis of pooled human AB+ serum 
(A), human serum albumin (B), crude supernatant preparation (C), 
and pool 6 of anion exchange fractionation (D) are shown.
Arrows Indicate lightly staining bands of Coomassie Blue.
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Gels loaded with a sample of Pool 6 were stained also with PAS 
to detect glycoproteins. The protein which took the Coomassle Blue 
did not stain with PAS (data not shown). The control proteint 
ovalbumin, (20 yg) accepted the stain and was visible approximately 
two thirds of way down the gel.
Isoelectric Focusing of Suppressive Supernatant Fluids. Sup­
pressor-active preparations were focused In gradients of pll 3-10,
4-7, or 5-8. The result of Isoelectric focusing through a pH gradient 
of 3-10 Is shown In Fig. 8. Signfiicant activity focused diffusely 
beginning at pH 4.4 and extending to pH 5.6. The most active fraction 
(No. 9) produced 70S suppression In the bloassay. In several exper­
iments, conducted In gradients of pH 3-10, 4-7, or 5-8, the pH range 
of significant activity was 4.3-6.3, and the mean pi was 5.0 ± 0.6 
(Table 7).
A control plate containing no protein was also focused (data 
not shown). Fractions were treated In a manner Identical to the 
experimental. There was no suppressor activity noted In the bloassays 
of control fractions.
Chromatofocuslng of Suppressor Supernatant Fluids. Suppressor 
active supernatant preparations were fractionated on chromatofocuslng 
columns using PB 74 as the eluent buffer. Fractions of 2.0 ml were 
collected and the pH of each fraction determined. The fractions were 
combined Into six equal pools. The first 5 fractions served as a 
column control in the bloassay. In two separate experiments, there 
was no demonstrable biological activity In any of the six poolB.
A control experiment was done to determine If the polybuffer 
interfered with con A stimulation of PBL. From this experiment (data
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Figure 8. Isoelectric Focusing of suppressor active 
tonsil supernatant using Pharmalytes (range: pH 3-10). 
Shaded area is percent suppression of individual fractions 
and pH (a— .
I 2 3 4 5 6 7 8 9 10 II 12 13 14 15 
Fraction Number
5 4
TABLE 7
Summary of Suppressor Isoelectric Points
Ampho lines*1 bRange
£
pi of Suppression
Ampholyte 3-10 4.26, 4.55
Ampholyte 3-10 4.75, 5.16
Ampholyte 3-10 4.27
Pharmalyte 3-10 4.4, 4.6, 4.88
5.25, 5.63, 6.3
Pharmalyte 4-7 5.41
Pharmalyte 5-8 5.0
Mean pi + S. D. ■ 5.0 ± 0.6
aBrand name of polyamino-polycarboxyllc acid.
b u 
pH range.
°Isoelectrlc point of significant suppressive fractions.
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not shown) It was learned that the blastogenic effect of con A was 
not significantly altered by the presence of nondlalyzable polybuffer 
constituents. That the suppressor was bound or Inhibited by the 
polybuffer was not investigated.
Anesthesia and Its Relationship to Suppressive Activity. Patients 
about to undergo tonsillectomy were anesthetized with combinations of 
the general anesthetics ethranc, nitrous oxide, and sodium pcntothnl.
To test the possibility that these drugs were related to the observed 
suppression, the mean per cent suppression for supernatant fluids from 
14 patients were classified according to the anesthesia used and 
analyzed by one way ANOVA (Table 8),
There was no significant difference between groups and it was 
concluded the anesthesia had no effect on the degree of suppression.
Mitogenlc Activity In Tonsil Supernatant Preparations. Concen­
trated crude supernatant fluids from tonsillar lymphocytes grown in 
the absence of serum or any stimulatory agent were tested for their 
ability to stimulate blastogenesis in allogeneic PBL.
As shown In Table 9, 13 of the 30 supernatants tested significantly
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stimulated the incorporation of H-thymldlne corresponding to 
mitogenlc Indices from 2 to 7.2. Fourteen supernatants had Mi's 
greater than one but less than two, while four supernatants had no 
significant effect. The mean mitogenlc Index was 2.4.
As also indicated by the data (Table 9), there was no apparent 
relationship between total protein in the crude preparation, primary 
culture blastogenesis and the degree of stimulation.
Augmentation In Tonsil Supernatant Fluids. In the bloassays for 
suppression, it was noted that several of the supernatant preparations
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TABLE 8 
Anesthesia
Group
I Ethrane, Pentothal
II Flourane, N20
III Ethrane, H20
Percent Suppressionb>c
31
11
11
64
40
7
13
16
83
30
11
44
45 
36
Anesthesia types grouped according to combination used. 
Percent suppression calculated as described In text.
'F from one-way analysis of variance was 0.0239. 
F^ ■ 11. No significant difference.
TABLE 9
Comparison of Mitogenlc Activity with Total Protein and Non-Induced Blastogenesis of Primary Culture
Supernatant Primary Protein
Number Volume® cpn^ Concentration® AB*^ MF cpme MI^
1 200 2,445 + 390 348 1,206 + 340 3,583 + 623 2.9
2 300 5,120 + 759 550 1,850 + 769 7,098 j- 119 3.8
3 300 3,029 + 668 464 1,654 + 675 6,296 * 463 5.0
4 300 9,288 + 1,415 600 1,097 + 564 7,919 977 7.2
5 300 5,262 ± 535 330 783 + 139 3,618 + 1,682 4.6
6 300 21,596 + 1,997 130 783 + 139 2,373 351 3.0
7 150 9,064 + 642 115 783 + 139 1,764 872 2.3
8 550 9,383 + 483 100 783 + 139 1,944 521 2.5
9 70 4,516 + 411 50 783 + 139 976 + 151 1.2
10 250 1,937 + 368 90 1,912 + 207 9,725 3,633 5.0
11 84 2,717 + 297 140 1,912 + 207 2,551 1,272 1.3
12 136 10,597 + 1,100 590 1,912 + 207 3,467 1,625 1.8
13 1000 12,430 + 1,433 580 799 + 277 712 272 KS
TABLE 9 (Cont)
Comparison of Mitogenlc Activity with Total Protein and Non-Induced Blastogenesis of Primary Culture
Supernatant Primary Protein
Number Volumea cpm Concentration11 AB MF cpme MF
14 600 7,193 + 871 340 799 + 277 1,125 + 238 1.4
15 200 18,790 + 816 160 799 + 277 1,359 + 376 1.7
16 116 7,694 + 992 150 942 + 360 4,229 3,128 4.5
17 100 3,380 ± 323 30 942 *■ 360 741 316 NS
18 600 7,373 + 1,188 330 942 * 360 1,103 266 1.2
19 830 15,016 + 1,568 1120 942 360 927 + 445 NS
20 247 12,878 + 1,337 320 942 £ 360 1,265 + 667 1.3
21 232 11,875 + 660 390 942 + 360 1,270 330 1.3
22 167 29,285 + 1,951 150 789 ± 344 670 * 225 NS
23 550 14,985 + 1,755 265 789 ± 344 1,386 597 1.8
24 550 7,967 + 843 300 789 ± 344 1,070 502 1.4
25 350 11,629 2,277 420 789 ± 344 835 + 505 NS
26 200 9,993 + 499 380 567 ± 211 954 4- 754 1.7
TABLE 9 (Cont)
Comparison of Mitogenlc Activity with Total Protein and Non-Induced Blastogenesis of Primary Culture
Supernatant
Number Volume*1
Primary
cpn£
Protein
Concentration*7
,_-kf
AB MF cpme MI*
27 200 9,522 ± 466 400 567 ± 211 1,178 t 174 2.0
28 200 8,260 ± 638 382 567 ± 211 2,194 ± 947 3.9
29 200 6,787 ± 595 460 567 ± 211 1,274 ± 663 2.2
Volume of original supernatant (ml).
lj
cpm ± S. D. (n * 6) of non-induced blastogenesis in the primary culture. 
CProtein concentration (fig/ml) in crude supernatant as determined by Lowry (97). 
^Cpm ± S. D. (n ■ 6) of AB+ control in bioassay.
Cpm ± S. D, (n ■ 6) of mitogenlc supernatant In bloassay.
■^Mitogenlc index calculated as described In text.
u»to
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had an enhancing effect on con A-induced blastogenesis. Since augmen­
tation required the presence of con A, the degre^ of enhancement (per 
cent augmentation) was calculated by comparing the tested supernatant 
cpm with the con A control (10 pg/ml) cpm. Significance was determined 
by taking the difference between means of test supernatant and control 
and establishing 95% confidence limits about the difference. The error 
used In calculating the limits was from one way ANOVA.
Of the many supernatant fluids tested in the suppressor/augmentor 
assay (Table 10), 14 caused significant Incorporation of ^H-thymidine 
greater than that of con A control values. The amount of augmentation 
varied greatly ranging from 12% to 211%.
When the per cent augmentation was compared with total protein 
and primary culture cpm, there was no observable relationship (Table 
11).
Mitogenlc Factor and Augmenting Dose Response Curves. In some 
supernatants it was possible to observe both mitogenlc and augmenting 
activities. Four of these supernatants were examined for dose 
responsiveness based on total protein In the crude preparation. Serial 
dilutions of the supernatants were made and subjected to the MF and 
suppressor/augmentor assays. Representative dose curves of a doubly 
active supernatant are shown in Figures 9 and 10. The mitogenlc 
activity (Fig. 9) behaved in a dose dependent fashion and seemed to 
approach a plateau of saturation at higher concentrations.
The slope of the dose response curve for augmentation (Fig. 10) 
was quite different from the dose curve obtained from MF. There was 
no apparent increase In cpm as a function of Increasing dosages. 
However, linear regression analysis revealed that the MF and augments-
TABLE 10
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal FBL Stimulated with Con A°
Experiment Sample
7} d g ^ q
Number Number cpm Augmentation A Keatr Significant"
1 Con AC 34,577 ± 8,875
1 107,547 ± 5,995 2112 +72,970 ± 13,135 +
2 50,489 + 12,085 462 +15,912 ± 13,135 +
2 Con A 79,793 ± 14,494
3 112,023 ± 3,852 402 +32,230 ± 16,696 +
3 Con A 99,711 ± 6,674
4 116,084 ± 5,541 162 +16,373 ± 14,583 +
A Con A 88,953 ±1,631
5 111,043 ± 6,845 252 +22,090 ± 6,407 +
5 Con A 69,331 ± 4,390
6 114,165 ± 23,763 652 +44,834 ± 25,398 +
7 108,589 20,744 572 +39,259 r 25,398 +
TABLE 10 (font)
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal FBL Stimulated with Con A
Experiment Sample
Number Number^ cpm* Augmentation6 A Mean/" Significant^
8 123,197 ± 14,310 782 +53,866 + 25,398 +
9 115,865 ± 14,184 672 +46,534 ± 25,398 +
6 Con AC 72,716 + 8,683
10 90,453 ± 10,794 242 +17,737 ± 14,167 +
7 Con A 62,972 + 8,403
11 81,782 + 7,183 302 +18,810 ± 10,484 +
8 Con A 64,986 ± 4,142
12 83,359 ± 3,529 282 +18,372 ± 8,530 +
9 Con A 71,770 ± 1,013
13 99,804 ± 3,451 392 +28,033 ± 8,890 +
10 Con A 63,022 ± 3,151
14 70,492 ± 1,687 122 + 7,469 ± 6,689 +
TABLE 10 (Cont)
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal PBL Stimulated with Con Aa
Experiment
Number
Sample
Number^ cpra^
g
Augmentation A Mean* Significant^
11 Con AC 73,984 ± 3,537
15 80,663 ± 10,336 92 + 6,679 ± 9,945 +
12 Con A 56,714 ± 2,673
16 62,609 ± 7,701 10% + 5,859 ± 10,272 -
17 65,966 ± 9,588 16% +9,252 ± 10,272 -
13 Con A 79,793 ± 14,494
18 88,234 ± 3,519 11% + 8,441 ± 16,696 -
cTonsil cells were cultured in the absence of stimulation. The supernatants were assayed by their
effect e on FBL cultured in the presence of Con A. 
b
Numerals refer to individual patients' tonsils.
Con A refers to radioactivity incorporated by PBL stimulated with Con A in the absence of tonsil 
cell culture fluid.
TABLE 10 (Cont)
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal PBL Stimulated with Con A
Mean cpm ± S. D. (n = 6).
Percent augmentation of radioactivity incorporated by PBL stimulated with Con A in the presence of 
tonsil cell culture fluid compared to that incorporated In the absence of tonsil cell culture fluids as 
described in text.
JThe difference between means of test supernatant and control ± 95% confidence limits about the 
difference.
“The error used to calculate limits was from analysis of variance.
(+) indicates significant augmentation.
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TABLE 11
Comparison of Augmentation with Total Protein and Non-Induced 
Blastogenesis of Primary Culture
Primary Culture Parameters 
Protein Concentration Volume Blastogenesis Bloassay of Primary Culture
(lig/ml)a (ml)^ (cpm)c Percent Augmentation
348 200 2,445 ± 390 30
550 300 5,120 ± 759 29
464 300 3,029 ± 668 33
600 300 9,288 ± 1,415 12
140 84 2,717 ± 297 40
590 136 10,597 ± 1,100 11
160 200 18,790 ± 816 18
150 116 7,694 ± 992 2
30 100 3,380 ± 323 7
1120 830 15,016 ± 1,568 7
320 247 12,878± 1,387 13
TABLE 11 (Cent)
Comparison of Augmentation with Total Protein and Non-Induced 
Blastogenesis of Primary Culture
Primary Culture Parameters
Supernatant Protein Concentration Volume Bias togenesls Bioassay of Primary Culture
Number (yg/ml)a (ml)* (cpm)C Percent Augmentation
12 390 232 11,875 ± 660 16
13 382 200 8,260 ± 638 7
14 460 200 6,787 ± 595 7
QProtein concentration (vg/ml) in primary culture supernatant preparation as determined by
Lowry technique (97).
£
Volume of original supernatant fluid (ml).
Cpm ± S. N. (n • 6) of non-induced blastogenesis of primary culture.
d
Percent suppression in bioassay of primary supernatant culture fluids.
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Figure 9. Serial dilutions of concentrated MF active 
supernatant fluids. Activity expressed in cpm as a function 
of total protein.
8000- 
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4000* 
3000- 
2000 • 
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Figure 10. Serial dilutions of concentrated augmenting 
active supernatant fluids. Activity expressed as percent 
augmentation as a function of total protein.
Percent Augmentation
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tion dose curves were more complex than straight lines (data not 
shown) and peak points of both curves were significant based on 
Dunnett's test.
Molecular Sieve Chromatography of Supernatant Fluids with 
Suppressor and Augroentor Activities. In experiments to determine the 
suppressor, it was possible to detect both suppressive and augmenting 
activities In a single supernatant preparation.
Fractionation on Sephadex G-100 of suppressor-active supernatant 
fluids (Fig. 5) repeatedly demonstrated one pool to contain the 
augmenting effect. The active fractions corresponded to the elution 
volume of carbonic anhydrase and, therefore, its apparent molecular 
weight was about 30,000,
Anion Exchange Chromatography of Augmenting Supernatant Fluids. 
Anion exchange chromatography of both suppressive and augmenting 
supernatant preparations was performed using a sodium chloride gradient 
of 0 to 1 M. Fractions of 1.0 ml were collected. The protein 
(OD220) content and conductivity of each fraction was determined, and 
then they were pooled as shown In Figure 11. The pools were prepared 
for the suppressor/augmentor assay In the usual manner and subsequently 
tested for augmenting activity.
In moBt experiments, augmentation was expressed In the 0.15 to
0.25 M Balt fractions regardless of the activity (i.e. suppression or 
augmentation observed in the assay of the crude preparation.)
Augmenting activity corresponded to the minor optical density peak of 
the biphaslc curve.
On one occasion, augmenting activity was noted In the 0.38 M 
salt fractions. There was, however, no detectable absorbance at
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Figure 11. Anion exchange chromatography of augmenting 
active supernatant fluid. OD22Q (M~~ ' * )• conductivity 
(mHo's; o •), percent augmentation (boxed area).
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0^220 t^iese fractions.
Determination of Augmentor Producing Cell Population. To deter­
mine the cellular origin of augmenting activity, tonsillar cells were 
separated on the basis of their adherence properties.
Although culture controls (Table 12) demonstrated significant 
augmentation with respect to con A control values, Dunnett's test 
(data not shown) Indicated there was no significant difference in the 
amount of augmentation observed in the culture controls and the 
adherent or non-adherent qualities of the cell population.
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Experiment
1
2
3
4
TABLE 12
Adherent Cel 1 Study For Augment inf;
Culture CPN^
Con A 72,716 J 8,683
Control^ 75,296 i 8,146
Adherent' 81,927 6,216
Non-Adherent 76,533 ± 5,654
Con A 72,716 + 8,683
Control 92,767 ± 10,797
Adherent OS o o ± 7,166
Non-Adherent 93,675 ± 10,586
Con A 37,829 ± 2,634
Control 45,639 ± 3,966
Adherent 37,735 ± 2,726
Non-Adherent 46,146 ± 4,499
Con A 74,804 + 8,350
Control 80,776 + 6,663
Adherent 79,454 ± 12,863
Non-Adherent 83,758 + 9,115
Con A 56,714 + 2,674
Control 70,613 ± 5,875
Adherent 74,607 ± 11,265
Non-Adherent 67,194 ± 9,619
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Adherent Cell Study for Augmenting
Experiment Culture CPM0
6 Con A
Control^
Adherent0 
Non-Adherent
aCpm ± S. D. (n ■ 6)
1-
Control cultures essayed sb usual 
^Adherent cell population allowed to adhere to tissue flask for 
2 hr, then the non-adherent cells was decanted. The adhered cells were 
rehydrated to the same volume. All cultures were Incubated for 24 hr.
59,485 l 5,439 
47,905 ± 7,760 
47,080 ± 8,817 
57,184 ± 6,010
CHAPTER 4 
DISCUSSION
Transformation and prollforation of small lymphocytes in viLrvj 
follows activation by antigens or by various mitogens. Among the 
consequences of activation is that both T and B lymphocytes secrete 
certain products called lymphoklnes (102)* and a rather large number 
of bloactlvltles have been attributed to these soluble mediators of 
Immune response. In vitro, lymphoklnes cause phenomena which mimic 
type IV tissue reactions* and more recent perceptions are that some 
of these functions immunoregulatory, It is widely presumed that 
lymphoklnes also are produced in vivo by lymphocytes activated by 
natural antigens.
Tonsils are lymphatic organs which comprise similar percentages 
of T and B lymphocytes (103, 104); and very low percentages of mono­
cytes (104). Their cells produce the lymphoklnes lymphotoxln (102), 
colony stimulating factor (106), T cell growth factor (54), and at least 
one suppressor factor (65) subsequent to in vitro activation. Since 
the proliferative response of tonsil cells in some humans is apparently 
evident by frequent episodes of tissue swelling, it is likely that 
tonsil cells would be engaged in Immunoregulatory activities. During 
the subsiding phase, it seems possible that suppression of cellular 
proliferation might be induced by a soluble mediator.
A major problem Inherent in the isolation and purification of 
most lymphoklnes has been the lack of substantial quantities of 
starting material for biochemical analysis. For this reason, it was 
thought that tonsils would provide a large and readily available 
source of lymphokine producing cells.
The cell culture methodology for both the primary tonsillar
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lymphocyte cultures and the bioassays had been well established in 
the literature and was adapted to these experiments with modifica­
tions, Unique to this study was the absence of serum during the 
primary culture, the use of Ficoll-Panue to Isolate the mononuclear 
fraction of the tonBillar tissue, and the absence of in vitro 
stimulation of the primary culture.
Normally, lymphocytes grown in primary culture for any length of 
time required at least 10% serum. However, it was found that the 
lack of serum in our cultures for 24 hr did not cause significant loss 
of viability. Furthermore, growth of these cells in media free from 
exogenous serum contaminants facilitated purification of 
endogenous protein.
Bouyant density flotation on Ficoll-Faque had been used routinely 
to Isolate mononuclear cellB from whole blood but rarely from tonsillar 
tissue. The use of Ficoll-Paque was chosen for these studies for two 
reasons. First, separation by Ficoll-Panue eliminated unwanted 
tonsillar cell types whose products may have interferred with the 
bioassay. Secondly, it was generally accepted that all three mono­
nuclear cell types i.e. T cells, B cells, and monocytes were required 
for the production of most lymphoklnes (107) and Ficoll-Paque effecti­
vely separated these cells (95% mononuclear cells) from other tonBil cells 
and debris, and Improved the yield of viable mononuclear cells.
Preliminary experiments in which con A was Incubated with the 
tonsillar lymphocytes and then subsequently removed by adsorption to 
Sephadex, revealed that supernatant fluids of cultures incubated with 
con A caused less H-thymldine Incorporation in the bioassay than did 
control cultures. This result was reasoned to he indicative of a
suppressive substance present in the supernatant preparation.
Tonsil lymphocytes were shown to be synthesizing DNA in the
absence of in vitro stimulation. The extent of incorporation of 
3
H-thytnidine by these cells varied from a few thousand to greater 
than ten thousand cpm at the time of measurement. These data 
confirmed those of Drucker et al. (108) who termed the phenomenon 
"preactivation11. Similar observations were made by Williams and 
Korsmeyer (109) in studies with human cord blood lymphocytes.
In these experiments, tonsil lymphocytes activated in vivo 
presumably as a consequence of naturally occurring antigen Insult 
secreted suppressive material which significantly inhibited the 
expected response of PBL to con A. This was in agreement with the 
work of Wolf et al. (65) who suggested that tonsil T lymphocytes 
elaborated a substance which suppressed the response of PBL to 
phytohemagglutinin and certain antigens.
The rather wide range of suppression percentages reported 
here probably were at least partially attributable to the genetic 
variability between the tonsillar cells and the donor target cells 
for the bloassay. To circumvent this problem, many different 
supernatant fluids were tested in a single assay as lagistlcally 
as possible. Ideally, lymphocytes from a single individual would 
have caused less heterogeneity with respect to suppression but this 
could not have been accomplished readily.
After the initial discovery of the suppressive activity, 
Btudles were undertaken to determine the relationship, between the 
degree of non-lnduced proliferation of the primary cultures, 
total protein in the crude preparations and the percent suppression
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In the bioassay.
Intuitively, one might predict that an Increase In total protein 
would be accompanied by an increase in percent suppression as well as 
an increase in non-induced blastogenesls of the primary culture. 
Similarly, one would expect a concomitant Increase in percent suppres­
sion and non-induced blastogenesls. However, data accumulated from 
several experiments indicated there was no correlative Increase or 
decrease in suppression as a function of any of the measured 
parameters.
The active substance apparently was protein since trypsin 
treatment of the crude preparation destroyed the suppressive effect 
in nearly all supernatant fluids tested. However, one supernatant 
preparation with a relatively high OD250 value, was still suppressive 
after enzyme treatment. This might have been due to the reported 
suppression of mitogen stimulation by nucleic acids (66).
The apparent molecular weight of the suppressor factor, as 
determined by molecular sieve chromatography, was >100,000. Attempts 
to further define the molecular weight by sieving through Sephadex 
G-200 and Bio Gel P-150 resulted in loss of biological activity.
Tlbbets et al. (91) described a suppressor which inhibited PHA 
stimulation of lymphoid cells. The factor was produced by mitogen- 
stimulated PBL and had an apparent molecular weight of >100,000 d.
The suppressor identified by Volf et al. (65) was also in excess 
0? 100,000 d.
The suppressor material adhered strongly to the anion exchanger 
DEAE, eluting in the 0.4 M-0.6 M salt fraction. This step in puri­
fication gave only a slight increase in specific activity. Folyacryl-
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amide gel electrophoresis showed more homogeneity of the anion 
exchange fraction with respect to the crude, concentrated prepara­
tion in that the active fraction contained one lightly staining 
band, while 7-8 bands were detected in the crude preparation. The 
gels, although loaded with concentrated partially purified suppressor, 
were not inbued to the extent that homogeneity was confirmed.
The rather diffuse range of isoelectric points reported here for 
the suppressor activity may belle charge heterogeneity. This heteroge­
neity was evidently not due to sugar residues since PAS staining (sen­
sitive to 5 pg) detected no glycoproteins for the concentrated, crude prep­
aration nor the active anion exchange fraction. Loss of amide groups, 
cycllzatlon of pyrollldone groups or non-specific aggregation of 
the suppressor with de novo protein in the primary culture mav 
account for the variation in charge.
The fact that the suppressor material was nondialy2able suggested 
that the activity was not attributable to thymidine secreted by 
monocyteB during generation of the supernatants (110), or to prosta­
glandins E, or The suppressor from the preactivated tonsil cells
was not the normal immunosuppressive protein described by others (7A, 75) 
and it was not some other serum-derived factor because neither plasma 
nor serum was present (72, 73, 76); nor was suppression due to comple­
ment components since heating at 56° C for 30 mln, which inactivates 
complement, had no effect on suppression. It was not likely that the 
suppressor was.a 1 bacterial - product such as endotoxin (111) or a fungal 
product elaborated during culture because prior to culture the tonsils 
or tonsil cells were kept in*media which was*heavily fortified with 
antibacterial and antifungal chemicals.. The culture medium was
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fortified also, and the cultures were aBceptic at harvest. The sup­
pressor apparently was not immunoglobulin fi, A, H, or E or a2- 
macroglobulin. It did not seem likely that u^-acld glycoprotein, 
which inhibited the response of lymphocytes to con A (77), could 
have been transferred on tonsil tissue in a quantity sufficient to 
be Inhibitory in our experiments.
The binding site of con A has been shown to be specific for 
a-D-manopyranose, a-D-glucopyranose or sterically similar residues 
(29) and, consequently, is specifically Inhibited by methyl-a-D 
manopyranose. The active fraction obtained from anion exchange 
chromatography, however, did not comprise any stalnable glycoproteins
and it was concluded that the suppression did not occur by nonspeci­
fic binding of con A to sugar moieties.
The viability of target cells consistently was 90% or greater.
Thus the suppressive agent did not act by causing extensive death 
of target lymphocytes. The suppressor was not lymphotoxln since 
this lymphoklne did not act on human lymphocytes.
It was suggested in the literature that certain general anes- 
therics (112, 113, 114) suppress the immune response by acting on 
lymphocytes. Rats Injected with 1.5% halothane developed a 
transient, reduced capacity to induce lysis of antibody-coated 
target cells compared with those from untreated animals. The 
result reported here Indicated statistically that suppression 
occurred irregardless of the type of anesthesia 
used.
In most supernatant culture fluids, suppression was the predomi­
nant biological activity observed. Occasionally, however, cultures
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comprised material which enhanced the expected activation of PHI. hy 
con A, Augmentation was also present in suppreBsor supernatant pre­
parations. Evidently, the suppressor masked the augmenting 
activity until separation of the two molecules was effected on 
G-100 or anion exchange chromatography columns.
It was possible that the enhancing effect was due to T cell 
growth factor since this lymphokine has been shown to augment the 
effect of mitogens (62). Warren et al. (66) previously reported that 
tonsillar T lymphocytes were capable of producing a T cell growth 
factor like substance which promoted the growth of lymphocytes in 
long term culture.
T cell growth factor has been shown to elute from anion exchange 
columns in 0.07M NaCl and to have an apparent molecular weight of 
15,000. In these experiments, however, the augmentor was eluted 
from the ion exchanger in 0.15-0.25 M NaCl and was shown to be 30,000 
in molecular weight. These discrepancies may possibly be accounted 
for by the aggregation of endogenous protein which has been shown to 
occur in cell cultures grown without serum (115).
Since T cell growth factor is produced by the non-adherent T 
lymphocyte, studies were undertaken to separate the tonsillar lympho­
cytes Into adherent and non-adherent populations. No definitive conclu­
sion could be drawn from these experiments presumably due to the Inability 
to adequately separate the two populations in the absence of serum.
In nearly all unstimulated tonsil lymphocyte supernatant fluids 
tested, there was at least minimal mitogenic activity present. Mlto- 
genlc factor apparently was different from the augmentor since (a) the 
mitogenic activity did not rumiire lectin co-wtlimitation for the
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expression of biological activity, (b) MF activity was dcmopstreble In 
the presence of the suppressor, while the augmentor was not, and (c) 
the dose response curves for the two activities, which were derived 
from the same supernatant fluids, were different shapes.
Some lymphokines are presumed to have an immunoregulatory role.
The suppressor, augmentor, and mitogenic factor described here may 
function to regulate cellular proliferation.. It is not yet certain 
that they act in a biologically relevant manner. They do inhibit 
or augment the proliferative response to a plant lectin or, as is 
the case with mitogenic factor, act independently of mitogen-stimulated 
blastogenesls; but these are experimental phenomena engineered in 
vitro. The mechanism of suppression, augmentation, and mitogenic 
activity Is not understood. However, the action of these molecules 
In the presence of one another in vitro may provide clues as to their 
in vivo functions.
In summary, our initial objectives were achieved In so much as we 
demonstrated the existence of three soluble factors produced by tonsil 
mononuclear cells which had different affectations on PBL prolifera­
tion. Furthermore, isolation and partial characterization of the 
suppressor factor was facilitated since there were no serum factors 
contaminating the primary cultures. Alternatively, we did not tonflrm 
lmmunoregulatory properties I.e. the relationship, between the three 
factors in vitro or in vivo.
These experiments have raised several questions which, If answered, 
would add to our understanding of how the immune system functions. For 
example, how can MF and the suppressor be present In the same superna­
tant; Is It produced by the same or different cell types? Secondly,
82
does Che suppressor Inhibit the augmentor stolchloraetrlcally? This 
could be determined only by first separating the two entitles then 
adding them back to each other In titrating doses. Thirdly, haw does 
the suppressor function mechanistically, i.e. does it directly affect 
con A target cells or does it turn on suppressor cells which then 
Inhibit the proliferation of con A responsive cells? j
In light of these questions, the immediate direction of this 
research seems evident. Initially, the anion exchange fraction 
containing suppressor activity should be submitted to PAGE and stained 
with silver stain. This would help determine purity since the silver 
stain is more sensitive than the Coomassle stain. Next, the same 
anion exchange fraction should be examined for trypsin sensitivity to 
eliminate the possibility of suppression by nucleic adds. Assuming 
these experiments yield the expected results, the anion exchange 
fraction could then be applied to generating rabbit anti-suppressor 
antibodies. Suppressor specific antisera would greatly facilitate 
further purification of the factor as well as help answer the immuno- 
regulatory questions presented above.
if
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